Blue Cross partnership debuts low-cost prostate cancer drug

PROVIDENCE – A company co-founded by Blue Cross & Blue Shield of Rhode Island, along with the Blue Cross Blue Shield Association and other BCBS health plans, has announced the debut of its first low-cost generic drug. CivicaScript, co-founded in 2020, says its first product, medication to treat prostate cancer that has spread to other…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.